Le Lézard
Classified in: Science and technology, Business
Subject: TNM

Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM[2]


ETTLINGEN, Germany, Feb. 22, 2018 /PRNewswire/ -- Bruker today announced that it has acquired IRM2, a developer of high-speed infrared (IR) imaging microscopes based on quantum cascade laser (QCL) technology. Innovative, fast QCL microscopy expands Bruker's technology portfolio and market opportunities for infrared microscopy, with applications in biological tissue analysis and materials science, and future potential in tissue diagnostics. Financial details of the transaction were not disclosed.

QCL-based IR microscope

QCL is a novel technology in infrared and Raman microscopy, with key customers at academic and government research institutions, as well as in pharmaceutical and biotechnology companies. The IRM2 QCL platform provides direct infrared imaging with detector arrays at very high speed. A proprietary coherence reduction technique delivers unprecedented image quality, so that the composition of large sample areas can be studied much more rapidly and at high lateral resolution.

Urban Fäh, President of Bruker Optics, stated: "Novel QCL technology can offer major speed advantages for infrared and Raman microscopy of large sampling areas, with great promise for the selective screening of biological tissues. The QCL microscopy technology expands our product portfolio, and we welcome the addition of the talented IRM2 team, which provides valuable new expertise."

Dr. Niels Kröger-Lui, founder and CEO of IRM2, commented: "The IRM2 team is proud to become part of Bruker. This is the next step in our vision of transferring the results of our academic research to industrial products that serve customers globally. We believe that Bruker provides the environment for IRM2 to integrate our know-how and technology into innovative and competitive QCL microscopy and spectroscopy solutions."

About Bruker Corporation (NASDAQ: BRKR)
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, phenomics and proteomics research, microbiology and molecular pathology research. For more information, please visit: www.bruker.com.

Investor Contact:

Media Contact for Bruker Optics: 

Miroslava Minkova

Michael Mueller

Head of Investor Relations

Marketing Manager 

Bruker Corporation

Bruker Optics

T: +1 (978) 663-3660, ext. 1479

T: +49 (7243) 504-2652

E: [email protected] 

E: [email protected]

SOURCE Bruker Corporation


These press releases may also interest you

at 09:10
Dexian, a leading provider of staffing, IT, and workforce solutions, today announced the launch of Dexian Futures, an online coding and career development program sponsored by Dexian. This groundbreaking program offers comprehensive instruction on...

at 09:10
Azul, the only company 100% focused on Java, today announced the recipients of its 2024 Channel Partner Awards honoring the outstanding performance and unwavering dedication of Azul's top-performing channel partners. These partners have been...

at 09:10
M-Files, the leader in knowledge work automation, today announced that M-Files founder and CEO, Antti Nivala, will present a solution keynote at the AIIM 2024 Conference in San Antonio, Texas. The event addresses the future of information management...

at 09:10
Modern Treasury, the operating system for the new era of payments, today announced the launch of its Professional Services offering to help enterprises scale modern payment infrastructure so they can innovate faster, reduce risk, and unlock new...

at 09:10
BioSkryb Genomics, a company ushering in the next generation of single-cell technology, will highlight how its ResolveDNA and ResolveOME single-cell assays can unravel the complexities of tumor evolution at the American Association for Cancer...

at 09:10
Archer, an enterprise leader in integrated risk management, today introduced Archer RMIS AI. This new offering leverages artificial intelligence (AI) to deliver a simplified, efficient RMIS user experience and enhance the effectiveness of enterprise...



News published on and distributed by: